# High-Risk Esophageal GIST: Imaging and Therapeutic Impact on Atypical Metastatic Lesions

**Authors:** Predrag Sabljak, Aleksandra Djuric-Stefanovic, Miljana Bubanja, Strahinja Odalovic, Nenad Ivanovic, Milica Mitrovic-Jovanovic, Ognjan Skrobic

PMC · DOI: 10.3390/diagnostics15141802 · 2025-07-17

## TL;DR

This paper presents a rare case of a gastrointestinal tumor in the esophagus that spreads unusually and responds to specific drug therapy.

## Contribution

The case highlights the importance of thorough diagnosis and treatment strategies for atypical tumor presentations.

## Key findings

- The tumor showed an unusual spread to lymph nodes and bones.
- Tyrosine kinase inhibitors effectively targeted the metastatic lesions.
- Comprehensive evaluation is crucial for managing complex tumor cases.

## Abstract

This case represents a relatively rare localization of a gastrointestinal stromal tumor involving the distal esophagus with a very unusual mode of metastatic spread to the lymph nodes and bone structures. Diagnostic follow-up showed the effect of tyrosine kinase inhibitor therapy on metastatic lesions, highlighting the necessity of comprehensive diagnostic evaluation in patients with atypical presentations and contributing to the improvement of therapeutic strategies in complex clinical scenarios.

## Linked entities

- **Chemicals:** tyrosine kinase inhibitor (PubChem CID 24956525)
- **Diseases:** gastrointestinal stromal tumor (MONDO:0011719)

## Full-text entities

- **Genes:** TXK (TXK tyrosine kinase) [NCBI Gene 7294] {aka BTKL, PSCTK5, PTK4, RLK, TKL}
- **Diseases:** Esophageal GIST (MESH:D046152)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293714/full.md

---
Source: https://tomesphere.com/paper/PMC12293714